Status | Study |
Active, not recruiting |
Study Name: Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients Condition: Proteinuria Idiopathic Membranous Nephropathy Date: 2011-06-29 Interventions: Drug: Repository Corticotropin Injection |
Recruiting |
Study Name: Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy Condition: Glomerulonephritis, Membranous Date: 2011-01-19 Interventions: Drug: Mycophenolate mofetil, low dose steroid |
Active, not recruiting |
Study Name: MEmbranous Nephropathy Trial Of Rituximab Condition: Idiopathic Membranous Nephropathy Date: 2010-08-10 Interventions: Drug: Rituximab 1000 mg, I.V. |
Completed |
Study Name: Treatment of Idiopathic Membranous Nephropathy With Tripterygium Wilfordii Plus Steroid vs Tacrolimus Plus Steroid Condition: Idiopathic Membranous Nephropathy Date: 2010-07-12 Interventions: Drug: Tripterygium wilfordii T |
Withdrawn |
Study Name: Aliskiren in Patients With Idiopathic Membranous Nephropathy Condition: Idiopathic Membranous Nephropathy Date: 2010-03-24 Interventions: Drug: Aliskiren Aliskiren dose will begin with 150mg per day and later up-titrated to the maximum availa |
Completed |
Study Name: Dose-Finding Pilot Study of ACTH in Patients With Idiopathic Membranous Nephropathy Condition: Idiopathic Membranous Nephropathy Date: 2008-12-09 Interventions: Drug: ACTH comparison of different dosages of drug O |
Completed |
Study Name: Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy Condition: Idiopathic Membranous Nephropathy Date: 2008-06-09 Interventions: Drug: tetracosactide hexacetaat Intramuscular injections with tetracosactide hexacetaat (Synacthen Depot |
Completed |
Study Name: To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN) Condition: Membranous Nephropathy Date: 2007-08-16 Interventions: Drug: TW TW,120mg/d Other Name: TW,Tripterygium wilf |
Completed |
Study Name: Rituximab in Membranous Nephropathy Condition: Membranous Nephropathy Date: 2007-01-19 Interventions: Drug: Rituximab |
Completed |
Study Name: Rituximab in the Treatment of Idiopathic Membranous Nephropathy Condition: Membranous Nephropathy Date: 2006-11-29 Interventions: Drug: Rituximab Patients will received rituximab 4 weekly doses of rituximab 375 mg/m2 at baseline. Pati |